AOD-9604 Product Brief (Ready-to-Sell Research Product Sheet)

1. Compound Overview

AOD-9604 (Anti-Obesity Drug 9604) is a modified fragment of human growth hormone consisting of amino acids 176–191 of the HGH molecule. It has been investigated for its potential role in fat metabolism without the growth-promoting effects associated with full HGH.

2. Mechanism of Interest

AOD-9604 is studied for its potential to:
• Stimulate lipolysis (fat breakdown)
• Inhibit lipogenesis (formation of new fat)
• Influence metabolic pathways associated with fat storage
• Avoid anabolic growth pathways linked to full HGH

3. Research Areas Being Explored

• Fat metabolism and adipose tissue regulation
• Weight management research
• Metabolic health studies
• Body composition research
• Potential cartilage and joint research

4. Suggested Research Vial Sizes

• 2 mg lyophilized vial
• 5 mg lyophilized vial
• 10 mg lyophilized vial
• 20 mg lyophilized vial

5. Example Reconstitution Chart

6. Label Information for Vials

• Compound name: AOD-9604
• Total amount per vial
• Lot / batch number
• Manufacturing date
• Storage instructions (2–8°C recommended)
• Research use only disclaimer

7. Market Positioning

AOD-9604 is commonly positioned in the metabolic research and fat metabolism category. It is often associated with research involving body composition and metabolic pathways.

8. Example Research Stack Categories

• AOD-9604 + Semaglutide
• AOD-9604 + Tirzepatide
• AOD-9604 + 5-Amino-1MQ
• AOD-9604 + MOTS-C
• AOD-9604 + L-Carnitine

9. Safety and Regulatory Notes

AOD-9604 is not approved by the FDA for medical treatment and is commonly distributed as a research compound. This document is intended for informational and research product description purposes only.